What is the recommended management of a central line-associated bloodstream infection (CLABSI)?

Management of Central Line-Associated Bloodstream Infection (CLABSI)

For suspected CLABSI, obtain paired blood cultures (one from the central line and one peripheral), start empiric vancomycin (or an anti-staphylococcal beta-lactam in low-MRSA settings), and remove short-term non-tunneled catheters promptly once cultures are positive, particularly for S. aureus or Candida species. 1

Initial Diagnostic Approach

When evaluating a febrile patient with a central venous catheter and no obvious alternative source:

• Obtain two sets of blood cultures simultaneously: one drawn from the central line and one from a peripheral venipuncture 1
• Label each blood culture bottle with the specific anatomic site or catheter used 1
• A shorter time to positivity from the central line compared to peripheral blood suggests catheter-related infection, though this finding has limited sensitivity 1
• Fever alone does not confirm CLABSI—consider alternative infectious and non-infectious causes 1

Critical caveat: Absence of fever does not exclude CLABSI, particularly in elderly, debilitated, or renally impaired patients who may not mount a febrile response 1

Empiric Antimicrobial Therapy

Standard Empiric Coverage

• Vancomycin is the appropriate first-line empiric agent while awaiting culture identification and susceptibilities 1
• In settings with low MRSA prevalence, an anti-staphylococcal beta-lactam (such as nafcillin or cefazolin) can be used instead 1

Expanded Coverage Indications

Add empiric Gram-negative coverage in the following high-risk scenarios 1:

• Severe sepsis or septic shock
• Neutropenic patients
• Immunocompromised hosts
• Femoral catheter placement
• Known institutional patterns of Gram-negative resistance

Appropriate Gram-negative agents include piperacillin/tazobactam, cefepime, or a carbapenem (such as meropenem), selected based on local antibiogram data 1

Catheter Management Strategy

Short-Term Non-Tunneled Central Venous Catheters

Remove promptly once blood cultures are positive, especially when no alternative infection source is identified 1

This includes 1:

• All peripheral venous and arterial catheters
• Midline catheters
• Short-term non-tunneled central venous catheters

Long-Term Catheters

For PICC lines, tunneled central lines, and implantable devices, explantation is recommended in most instances 1

Catheter salvage with antimicrobial locks is unlikely to be effective but may be considered under specific circumstances for long-term catheters 1

Organism-Specific Removal Recommendations

Mandatory removal 1:

• S. aureus CLABSI (both MSSA and MRSA)
• Candida species CLABSI
• Persistent bacteremia/fungemia >72 hours despite appropriate antimicrobials

Consider removal 1:

• Gram-negative bacilli CLABSI
• Enterococcal CLABSI

May retain with close monitoring 1:

• Uncomplicated coagulase-negative staphylococcal CLABSI in low-risk patients (no intravascular foreign body, fever resolves within 72 hours)

Antibiotic Duration by Organism

Coagulase-Negative Staphylococci

• Uncomplicated (fever resolves <72 hours): 5-7 days after catheter removal 1
• Complicated: 10-14 days 1

Staphylococcus aureus

• Uncomplicated: 14 days minimum after catheter removal 1
• Bacteremia persisting >72 hours after catheter removal and appropriate antibiotics: Minimum 4-6 weeks (evaluate for endocarditis and osteomyelitis) 1
• S. aureus carries high risk for metastatic complications including endocarditis and osteomyelitis 1

Enterococcus

• 7-14 days after catheter removal 1

Gram-Negative Bacilli

• 7-14 days after catheter removal 1
• Longer duration may be needed based on severity 1

Candida Species

• Remove catheter promptly 1
• 14 days after the first negative blood culture 1

Targeted Therapy Adjustments

Once susceptibilities are available:

• Switch from vancomycin to a beta-lactam antibiotic for beta-lactam-susceptible staphylococcal CLABSI in patients without beta-lactam allergy 1
• This de-escalation strategy reduces vancomycin exposure and associated toxicities

Monitoring for Complications

Indications for Extended Therapy (4-6 weeks)

Evaluate for and treat with prolonged antimicrobials if secondary complications develop 1:

• Endocarditis (particularly with S. aureus)
• Osteomyelitis
• Septic thrombophlebitis
• Other metastatic infections

Persistent Bacteremia Management

Any persistent bacteremia despite appropriate antimicrobials mandates prompt catheter removal if not already done 1

Common Pitfalls to Avoid

• Do not perform guidewire exchange for suspected CLABSI—this increases risk of infection with the new catheter 1
• Do not delay catheter removal in S. aureus or Candida CLABSI, as this significantly worsens outcomes 1
• Do not assume all fever in catheterized patients is CLABSI—thoroughly evaluate for alternative sources 1
• Do not use antimicrobial locks as primary therapy for established CLABSI—they are ineffective for treatment 1
• Do not forget to evaluate for metastatic complications with S. aureus bacteremia, even if initial symptoms resolve 1